BRCA2 and ovarian cancer: Furthermore, women with genetic mutations in the BRCA1- and BRCA2-associated hereditary breast and ovarian cancer (HBOC) syndrome at risk of developing breast and ovarian cancer [50–52] opt for oocyte cryopreservation prior to a prophylactic oophorectomy at an early age.